| 摘要 |
The present invention relates to the development of an in vivo assay system, useful for developing therapeutic options by testing the efficacy of drugs and other substances, said system constituting a novel, fast, and inexpensive in vivo assay system wherein, transgenic Drosophila harbors human Adenomatous Polyposis Coli gene, a negative regulator of beta-catenin.
|
